Benitec Biopharma (BNTC) Return on Sales [ROS] (2019 - 2024)
Benitec Biopharma's Return on Sales [ROS] came in at -307028.57% for fiscal Q3 2024 (quarter ended Mar 31, 2024), down 298989.68 percentage points from -8038.89% a year earlier and down 271467.92 percentage points from the prior quarter.
Powered by 
Analysis
Benitec Biopharma (BNTC) Return on Sales [ROS] (2019 - 2024) Analysis & Trends
For FY2023 (ended Jun 30, 2023), Benitec Biopharma's Return on Sales [ROS] was -25441.33%, down 983.80 percentage points from FY2022.
- Return on Sales [ROS] has declined in each of the last four fiscal years, with a four-year change of -25462.51 percentage points (FY2019 to FY2023).
- Going back by fiscal year, Return on Sales [ROS] was -24457.53% in FY2022 (-1413.47 pp), -23044.07% in FY2021 (-14925.44 pp), -8118.63% in FY2020 (-8139.80 pp) and 21.17% in FY2019.
- The fiscal Q3 2024 figure represents the lowest quarterly Return on Sales [ROS] since fiscal Q1 2022.
- Year-over-year, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of +22220.93 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q3 2022 (a gain of 372091.67 percentage points), and the weakest in fiscal Q1 2022 (a drop of 388334.09 percentage points).
- Business Quant data shows BNTC's Return on Sales [ROS] at -35560.66% (Q2 2024), -27166.67% (Q1 2024) and -65000.00% (Q4 2023) in the three fiscal quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Benitec Biopharma | 418.09 Mn | 418.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -307,028.57% |
| Dec 31, 2023 | -35,560.66% |
| Sep 30, 2023 | -27,166.67% |
| Jun 30, 2023 | -65,000.00% |
| Mar 31, 2023 | -8,038.89% |
| Dec 31, 2022 | -40,071.43% |
| Sep 30, 2022 | -24,127.40% |
| Jun 30, 2022 | -24,458.90% |
| Mar 31, 2022 | -7,208.33% |
| Dec 31, 2021 | -19,340.00% |
| Sep 30, 2021 | -393,225.00% |
| Jun 30, 2021 | -192,750.00% |
| Mar 31, 2021 | -379,300.00% |
| Dec 31, 2020 | -325,900.00% |
| Sep 30, 2020 | -4,890.91% |
| Jun 30, 2020 | -8,033.98% |
| Mar 31, 2020 | -7,539.29% |
| Dec 31, 2019 | -2,741.56% |
| Sep 30, 2019 | -3,533.33% |
API Access
Benitec Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();